0000704415-16-000060.txt : 20160225 0000704415-16-000060.hdr.sgml : 20160225 20160225162209 ACCESSION NUMBER: 0000704415-16-000060 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160225 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160225 DATE AS OF CHANGE: 20160225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHWAYS, INC CENTRAL INDEX KEY: 0000704415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 621117144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19364 FILM NUMBER: 161456238 BUSINESS ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 6156144929 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHWAYS INC DATE OF NAME CHANGE: 20000322 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHCORP INC /DE DATE OF NAME CHANGE: 19940211 8-K 1 form8-k_022516.htm HEALTHWAYS, INC. FORM 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________
FORM 8‑K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 25, 2016
HEALTHWAYS, INC.
(Exact name of registrant as specified in its charter)
Delaware
 
000-19364
 
62-1117144
 
(State or other jurisdiction of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
701 Cool Springs Boulevard
Franklin, Tennessee
 
 
37067
(Address of principal executive offices)
 
(Zip Code)

(615) 614-4929
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

Item 2.02 Results of Operations and Financial Condition.
 
         On February 25, 2016, Healthways, Inc. issued a press release announcing earnings results for the fourth quarter and fiscal year ended December 31, 2015, the text of which is attached hereto as Exhibit 99.1.  This information furnished pursuant to this Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:
 
 
Exhibit 99.1
 
Press Release.
 
 
 
 
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
HEALTHWAYS, INC.
 
 
 
 
 
By:
/s/ Alfred Lumsdaine
 
 
Alfred Lumsdaine
 
 
Chief Financial Officer

Date:  February 25, 2016 

EXHIBIT INDEX


  
Exhibit 99.1
 
Press Release dated February 25, 2016



 

 EX-99.1 2 ex991_022516.htm EX-99.1, PRESS RELEASE
Exhibit 99.1

 
 
 Investor Relations Contact:
 
 
Chip Wochomurka
 
 
(615) 614-4493
 
 
 chip.wochomurka@healthways.com

HEALTHWAYS REPORTS FOURTH-QUARTER 2015 FINANCIAL RESULTS
¾¾¾¾¾¾¾¾¾¾¾
Establishes Financial Guidance for 2016

NASHVILLE, Tenn. (February 25, 2016) – Healthways (NASDAQ: HWAY) today announced financial results for the fourth quarter and year ended December 31, 2015.

Fourth-Quarter 2015 Financial Highlights

·
Revenues of $186.3 million compared with $199.1 million for the fourth quarter of 2014;
·
Net loss of $19.4 million, or $0.54 per share, compared with net income of $2.6 million, or $0.07 per diluted share, for the fourth quarter of 2014; and
·
Adjusted net loss per share of $0.04 compared with adjusted net income per diluted share of $0.25 for the fourth quarter of 2014. The adjusted results for the fourth quarter of 2015 exclude $13.3 million of restructuring charges; $9.6 million to establish a deferred tax asset valuation allowance; $1.8 million of non-cash interest expense; and a $1.9 million gain on the sale of the Company's Navvis subsidiary. The adjusted results for the fourth quarter of 2014 exclude $8.4 million for the impact of two legal settlements and $1.7 million of non-cash interest expense.

 
HEALTHWAYS, INC.
Financial Highlights
(In millions, except per-share data)
See pages 9-11 for a reconciliation of non-GAAP financial measures
 
   
Three Months Ended
December 31
    
Year Ended
December 31
  
   
2015
    
2014
    
2015
    
2014
  
Revenue
  
$
186.3
     $
199.1
     $
770.6
     $
742.2
  
Net (loss) income
    
(19.4
 )     
2.6
      
(30.9
 )     
(5.6
 ) 
                                 
Net (loss) income per share, GAAP basis
    
(0.54
 )2   $
0.07
 1   $
(0.86
 )2   $
(0.16
 )2 
Non-cash interest expense per share
    
0.03
  2     
0.03
 1     
0.12
  2    
0.12
  2
Restructuring charges per share
    
0.23
 2
    
—
      
0.26
  2    
—
  
Deferred tax asset valuation allowance per share
    
0.27
  2    
—
      
0.27
  2     
—
  
Gain on sale of Navvis per share
    
(0.03
 )2    
—
      
(0.03
 )2    
—
  
Joint venture impairment loss and related loss per share
    
—
      
—
      
0.33
 2    
—
  
CEO transition-related expenses per share
    
—
      
—
      
0.08
 2    
—
  
Legal settlement charges per share
    
—
      
0.15
 1     
—
      
0.32
  2 
Adjusted net (loss) income per share
  
$
(0.04
 )2   $
0.25
 1   $
0.16
  1    $
0.27
 1

1 Diluted
2 Basic
3 Figures may not add due to rounding and use of basic or diluted shares in calculation
 
- MORE -
HWAY Reports Fourth-Quarter Results
Page 2
February 25, 2016
 
"Our fourth-quarter financial results brought our full-year 2015 revenues and adjusted earnings per diluted share slightly above our guidance," commented Donato Tramuto, Healthways Chief Executive Officer.  "As anticipated, the decline in our top and bottom-line results for the fourth quarter compared to the fourth quarter of 2014 reflect the earlier than expected recognition of performance-based fees in the second and third quarter of 2015 that were originally expected in the fourth quarter, the amended ten-year contract with The Hawai'i Medical Service Association (HMSA) and the sale of Navvis."

Alfred Lumsdaine, Healthways Chief Financial and Chief Administrative Officer, added, "For the full year, our adjusted EBITDA margin was 9.2%, which excludes the restructuring charges, joint venture investment impairment and related loss on the remaining investment commitment, CEO transition-related expenses and gain on the sale of Navvis. Operating cash flow for the year was $61.0 million and capital expenditures were $34.7 million.  At the end of 2015, the Company's ratio of total debt to EBITDA, as calculated under the amended credit facility, was 2.9.

"We have made significant progress in our structural reorganization and cost rationalization plan, which we announced in late October.  In the fourth quarter, we incurred $13.3 million of the now expected total cost of approximately $25 million related to this plan, bringing the total to $15.1 million during 2015.  We expect to complete the plan over the course of the first three quarters of 2016 and continue to expect resulting annual gross cost savings in 2017 in a range of $35 million to $45 million."

Mr. Tramuto concluded, "We believe a critical element of this plan – the establishment of a proven, best-in-class leadership team – has now been completed with the addition of Sid Stolz as President, Network Solutions, Sean Slovenski as President, Population Health Services and Steve Schwartz as Senior Vice President of Strategy and Corporate Development. The additions of these talented leaders will facilitate our ongoing strategic review of our business, which, as previously noted, is on track to be concluded during the second quarter."

2016 Financial Guidance

Healthways today has established its financial guidance for 2016, as follows:

·
Adjusted for an aggregate year over year revenue reduction of $39 million from the HMSA contract amendment and the sale of Navvis, guidance for 2016 revenue is for a percentage growth rate in the low to middle single digits range.
·
Beginning in 2016, the Company will exclude non-cash share-based compensation from adjusted EBITDA. Guidance for 2016 adjusted EBITDA, which also excludes restructuring charges, is in a range of $85 million to $90 million, compared with adjusted EBITDA for 2015 of $80 million, which excludes non-cash share-based compensation, restructuring charges, joint venture investment impairment and related loss on the remaining investment commitment, CEO transition-related expenses and gain on the sale of Navvis.
·
The Company expects to use its free cash flow to reduce its debt by at least $30 million at December 31, 2016, compared with December 31, 2015.
 
Conference Call

Healthways will hold a conference call to discuss this release today at 5:00 p.m. Eastern Time. Investors will have the opportunity to listen to the conference call live over the Internet by going to www.healthways.com and clicking Investors at least 15 minutes early to register, download and install any necessary audio software. Presentation materials related to the conference call may also be accessed by going to www.healthways.com and clicking Investors. For those who cannot listen to the live broadcast, a telephonic replay will be available for one week at 719-457-0820, code 3970444, and the replay will also be available on the Company's web site for the next 12 months.
 
- MORE -

HWAY Reports Fourth-Quarter Results
Page 3
February 25, 2016
 
Safe Harbor Provisions

This press release contains forward-looking statements, including our guidance and financial expectations for future periods, which are based upon current expectations, involve a number of risks and uncertainties and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings and results of operations. Those forward-looking statements are subject to the finalization of the Company's quarterly financial accounting procedures and may be affected by certain risks and uncertainties, including, but not limited to:
·
the Company's ability to estimate the costs associated with, and to implement and realize the anticipated benefits of, the structural reorganization and cost rationalization plan;
·
the effectiveness of management's strategies and decisions and the ability to conclude the strategic review of the business on the anticipated timeframe;
·
the Company's ability to sign and implement new contracts for our solutions;
·
the Company's ability to accurately forecast the costs required to successfully implement new contracts;
·
the Company's ability to accurately forecast the costs necessary to integrate new or acquired businesses, services (including outsourced services) or technologies into the Company's business;
·
the Company's ability to achieve estimated annualized revenue in backlog in the manner and within the timeframe we expect, which is based on certain estimates regarding the implementation of our services;
·
the Company's ability to anticipate change and respond to emerging trends in the domestic and international markets for healthcare and the impact of the same on demand for the Company's services;
·
the Company's ability to implement its integrated data and technology solutions platform within the required time frame and expected cost estimates and to develop and enhance this platform and/or other technologies to meet evolving customer and market needs;
·
the Company's ability to renew and/or maintain contracts with its customers under existing terms or restructure these contracts on terms that would not have a material negative impact on the Company's results of operations;
·
the Company's ability to accurately forecast the Company's revenues, margins, earnings and net income, as well as any potential charges that the Company may incur as a result of changes in its business and leadership;
·
the Company's ability to accurately forecast performance and the timing of revenue recognition under the terms of its customer contracts ahead of data collection and reconciliation;
·
the Company's ability to accurately forecast enrollment and participation rates in services and programs offered within the Company's contracts;
·
the risks associated with deriving a significant concentration of revenues from a limited number of customers;
·
the risks associated with foreign currency exchange rate fluctuations;
 
- MORE -
HWAY Reports Fourth-Quarter Results
Page 4
February 25, 2016
 
·
the ability of the Company's customers to provide timely and accurate data that is essential to the operation and measurement of the Company's performance;
·
the Company's ability to achieve the contractually required cost savings and clinical outcomes improvements and reach mutual agreement with customers with respect to cost savings, or to achieve such savings and improvements within the time frames it contemplates;
·
the risks associated with changes in macroeconomic conditions;
·
the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions of our information systems or those of third-party vendors or other service providers, which may result in unauthorized access by third parties to customer, employee or Company information or patient health information and lead to enforcement actions, fines and other litigation against the Company;
·
the Company's ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed our resources;
·
the Company's ability to service its debt and remain in compliance with its debt covenants;
·
counterparty risk associated with our interest rate swap agreements and foreign currency exchanged contracts;
·
the impact of litigation involving the Company and/or its subsidiaries;
·
the impact of future state, federal and international legislation and regulations applicable to the Company's business, including the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 on the Company's operations and/or demand for its services; and
·
other risks detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, and other filings with the Securities and Exchange Commission.

The Company undertakes no obligation to update or revise any such forward-looking statements.

About Healthways

Healthways is the largest independent global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the Company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities.  We provide highly specific and personalized support for each individual and their team of experts to optimize each participant's health and productivity and to reduce health-related costs. Results are achieved by addressing longitudinal health risks and care needs of everyone in a given population. The Company has scaled its proprietary technology infrastructure and delivery capabilities developed over 30 years and now serves approximately 68 million people on four continents. Learn more at www.healthways.com.

- MORE -
HWAY Reports Fourth-Quarter Results
Page 5
February 25, 2016


HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(In thousands, except earnings (loss) per share data)

   
Three Months Ended
    
Twelve Months Ended
  
   
December 31,
    
December 31,
  
   
2015
    
2014
    
2015
    
2014
  
                 
Revenues
  
$
186,281
    
$
199,136
    
$
770,598
    
$
742,183
  
Cost of services (exclusive of depreciation and amortization of $10,281, $9,373, $39,485, and $37,741, respectively, included below)
    
156,762
      
154,705
      
635,909
      
598,280
  
Selling, general & administrative expenses
    
16,499
      
16,292
      
68,142
      
65,377
  
Depreciation and amortization
    
12,756
      
13,128
      
49,855
      
53,378
  
Restructuring and related charges
    
13,345
      
—
      
15,097
      
—
  
Gain on sale of business
    
(1,873
)
    
—
      
(1,873
)
    
—
  
Legal settlement charges
    
—
      
8,352
      
—
      
17,715
  
                                 
Operating income (loss)
    
(11,208
)
    
6,659
      
3,468
      
7,433
  
 Interest expense
    
4,843
      
4,108
      
18,328
      
17,581
  
 Equity in income (loss) from joint ventures
    
214
      
—
      
(20,229
)
    
—
  
                                 
Income (loss) before income taxes
    
(15,837
)
    
2,551
      
(35,089
)
    
(10,148
)
Income tax expense (benefit)
    
3,542
      
(27
)
    
(3,771
)
    
(4,587
)
                                 
Net income (loss)
  
$
(19,379
)
  
$
2,578
    
$
(31,318
)
  
$
(5,561
)
Less: net income (loss) attributable to non-controlling interest
    
49
      
—
      
(371
)
    
—
  
Net income (loss) attributable to Healthways, Inc.
  
$
(19,428
)
  
$
2,578
    
$
(30,947
)
  
$
(5,561
)
                                 
Earnings (loss) per share attributable to Healthways, Inc.:
                                
  Basic
  
$
(0.54
)
  
$
0.07
    
$
(0.86
)
  
$
(0.16
)
                                 
  Diluted (1)
  
$
(0.54
)
  
$
0.07
    
$
(0.86
)
  
$
(0.16
)
                                 
Comprehensive income (loss)
  
$
(19,015
)
  
$
1,651
    
$
(33,509
)
  
$
(7,202
)
Less: comprehensive income (loss) attributable to non-controlling interest
    
59
      
—
      
(523
)
    
—
  
Comprehensive income (loss) attributable to Healthways, Inc.
  
$
(19,074
)
  
$
1,651
    
$
(32,986
)
  
$
(7,202
)
                                 
Weighted average common shares
                                
and equivalents:
                                
Basic
    
36,060
      
35,417
      
35,832
      
35,302
  
Diluted (1)
    
36,060
      
36,560
      
35,832
      
35,302
  
                                 
(1)The impact of potentially dilutive securities for the three and twelve months ended December 31, 2015 and the twelve months ended December 31, 2014 was not considered because the effect would be anti-dilutive in each of those periods.
  
- MORE -
HWAY Reports Fourth-Quarter Results
Page 6
February 25, 2016
HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands)

ASSETS
   
December 31,
  
 
December 31,
  
   
2015
  
 
2014
  
Current assets:
        
Cash and cash equivalents
  
$
1,870
  
 
$
1,765
  
Accounts receivable, net
    
108,195
      
126,559
  
Prepaid expenses
    
10,207
      
10,680
  
Other current assets
    
5,230
      
7,662
  
Income taxes receivable
    
1,076
      
2,917
  
Deferred tax asset
    
8,209
      
13,118
  
  Total current assets
    
134,787
      
162,701
  
                 
Property and equipment:
                
Leasehold improvements
    
37,565
      
39,285
  
Computer equipment and related software
    
315,890
      
316,808
  
Furniture and office equipment
    
19,776
      
23,257
  
Capital projects in process
    
13,676
      
38,389
  
     
386,907
      
417,739
  
Less accumulated depreciation
    
(230,907
)
    
(252,043
)
     
156,000
      
165,696
  
                 
Other assets
    
27,919
      
75,550
  
Intangible assets, net
    
61,317
      
69,161
  
Goodwill, net
    
336,974
      
338,800
  
                 
Total assets
  
$
716,997
  
 
$
811,908
  
                 
 

- MORE -
HWAY Reports Fourth-Quarter Results
Page 7
February 25, 2016

HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)

LIABILITIES AND STOCKHOLDERS' EQUITY

   
December 31,
    
December 31,
  
   
2015
    
2014
  
Current liabilities:
        
Accounts payable
  
$
41,035
    
$
37,204
  
Accrued salaries and benefits
    
21,620
      
24,198
  
Accrued liabilities
    
50,074
      
62,674
  
Deferred revenue
    
7,056
      
8,282
  
Contract billings in excess of earned revenue
    
12,893
      
15,232
  
Current portion of long-term debt
    
23,308
      
20,613
  
Current portion of long-term liabilities
    
6,204
      
2,127
  
Total current liabilities
    
162,190
      
170,330
  
                 
Long-term debt
    
212,362
      
231,112
  
Long-term deferred tax liability
    
23,617
      
32,883
  
Other long-term liabilities
    
38,238
      
72,993
  
                 
Stockholders' equity:
                
Preferred stock
                
      $.001 par value, 5,000,000 shares
                
authorized, none outstanding
    
—
      
—
  
Common stock
                
      $.001 par value, 120,000,000 shares authorized,
                
        36,079,446 and 35,511,221 shares outstanding, respectively
    
36
      
35
  
Additional paid-in capital
    
302,488
      
292,346
  
Retained earnings
    
9,659
      
42,439
  
Treasury stock, at cost, 2,254,953 shares in treasury
    
(28,182
)
    
(28,182
)
Accumulated other comprehensive loss
    
(4,087
)
    
(2,048
)
Total Healthways, Inc. stockholders' equity
    
279,914
      
304,590
  
Non-controlling interest
    
676
      
—
  
  Total stockholders' equity
    
280,590
      
304,590
  
                 
Total liabilities and stockholders' equity
  
$
716,997
    
$
811,908
  
                 

- MORE -
HWAY Reports Fourth-Quarter Results
Page 8
February 25, 2016

HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)

 
  
Twelve Months Ended
  
   
December 31,
  
   
2015
    
2014
  
Cash flows from operating activities:
        
Net loss
  
$
(31,318
)
  
$
(5,561
)
Adjustments to reconcile net loss to net cash provided by
                
operating activities:
                
Depreciation and amortization
    
49,855
      
53,378
  
Amortization of deferred loan costs
    
2,520
      
1,855
  
Amortization of debt discount
    
7,148
      
6,757
  
Share-based employee compensation expense
    
10,469
      
8,349
  
Equity in loss from joint ventures
    
20,229
      
—
  
Deferred income taxes
    
(5,916
)
    
(6,972
)
Gain on sale of business
    
(1,873
)
    
—
  
Excess tax benefits from share-based payment arrangements
    
—
      
(525
)
Decrease (increase) in accounts receivable, net
    
16,971
      
(38,130
)
Decrease in other current assets
    
2,796
      
1,589
  
Increase (decrease) in accounts payable
    
5,248
      
(9,343
)
(Decrease) increase in accrued salaries and benefits
    
(4,345
)
    
3,165
  
(Decrease) increase in other current liabilities
    
(11,764
)
    
26,990
  
Other
    
940
      
10,546
  
Net cash flows provided by operating activities
    
60,960
      
52,098
  
                 
Cash flows from investing activities:
                
Acquisition of property and equipment
    
(34,730
)
    
(42,991
)
Investment in joint ventures
    
(5,881
)
    
(7,050
)
Proceeds from sale of business
    
4,369
      
—
  
Other
    
(1,121
)
    
(1,164
)
Net cash flows used in investing activities
    
(37,363
)
    
(51,205
)
                 
Cash flows from financing activities:
                
Proceeds from issuance of long-term debt
    
572,981
      
467,126
  
Payments of long-term debt
    
(597,837
)
    
(481,515
)
Deferred loan costs
    
(892
)
    
(391
)
Excess tax benefits from share-based payment arrangements
    
—
      
525
  
Exercise of stock options
    
2,467
      
2,851
  
Repurchase of common stock
    
(1,833
)
    
—
  
Proceeds from non-controlling interest
    
1,615
      
—
  
Change in cash overdraft and other
    
1,648
      
11,227
  
Net cash flows used in financing activities
    
(21,851
)
    
(177
)
                 
Effect of exchange rate changes on cash
    
(1,641
)
    
(1,535
)
                 
Net increase (decrease) in cash and cash equivalents
    
105
      
(819
)
                 
Cash and cash equivalents, beginning of period
    
1,765
      
2,584
  
                 
Cash and cash equivalents, end of period
  
$
1,870
    
$
1,765
  

- MORE -
HWAY Reports Fourth-Quarter Results
Page 9
February 25, 2016


HEALTHWAYS, INC.
RECONCILIATION OF NON-GAAP MEASURES TO GAAP MEASURES
(Unaudited)
 
Reconciliation of Adjusted Net Income Per Share Attributable to Healthways, Inc. ("Adjusted EPS") to
Net Income (Loss) Per Share Attributable to Healthways, Inc., GAAP Basis ("EPS")

   
Three Months Ended
December 31,
    
Twelve Months Ended
December 31,
  
   
2015
    
2014
    
2015
    
2014
  
Adjusted EPS (1)
  
$
(0.04
)
  
$
0.25
    
$
0.16
    
$
0.27
  
EPS (loss) attributable to non-cash interest charges (2)
    
(0.03
)
    
(0.03
)
    
(0.12
)
    
(0.12
)
EPS (loss) attributable to restructuring charges (3)
    
(0.23
)
    
—
      
(0.26
)
    
—
  
EPS (loss) attributable to impairment charge and loss on related purchase commitment (4)
    
—
      
—
      
(0.33
)
    
—
  
EPS (loss) attributable to CEO transition-related expenses (5)
    
—
      
—
      
(0.08
)
    
—
  
EPS (loss) attributable to valuation allowance against U.S. deferred tax assets (6)
    
(0.27
)
    
—
      
(0.27
)
    
—
  
EPS (loss) attributable to gain on sale of business (7)
    
0.03
      
—
      
0.03
      
—
  
EPS (loss) attributable to legal settlement charges (8)
    
—
      
(0.15
)
    
—
      
(0.32
)
EPS (loss), GAAP basis (9)
  
$
(0.54
)
  
$
0.07
    
$
(0.86
)
  
$
(0.16
)
                                 

(1) Adjusted EPS is a non-GAAP financial measure.  The Company excludes EPS (loss) attributable to non-cash interest charges, restructuring charges, impairment charge and related loss, CEO transition-related expenses, valuation allowance against U.S. deferred tax assets, gain on the sale of business, and legal settlement charges from this measure because of its comparability to the Company's historical operating results.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider Adjusted EPS in isolation or as a substitute for EPS (loss) attributable to Healthways, Inc. determined in accordance with accounting principles generally accepted in the United States.

(2) EPS (loss) attributable to non-cash interest charges consists of pre-tax charges of $1,840,000 and $1,739,000 for the three months ended December 31, 2015 and 2014, respectively, and $7,148,000 and $6,756,000 for the twelve months ended December 31, 2015 and 2014, respectively,  associated with amortization of a debt discount. The tax rate applied to these non-cash interest charges was 39.55%, which represented the combined estimated U.S. federal and state statutory tax rate.

(3) EPS (loss) attributable to restructuring charges consists of pre-tax charges of $13,345,000 and $15,097,000 for the three and twelve months ended December 31, 2015, respectively, associated with a Company reorganization and rationalization plan.  The tax rate applied to these restructuring charges was 39.55%, which represented the combined estimated U.S. federal and state statutory tax rate, except for pre-tax charges of $1,176,000 for the three months ended December 31, 2015 attributable to the foreign jurisdictions for which a rate of 30.6% was applied.

(4) EPS (loss) attributable to impairment charge and loss on related purchase commitment consists of pre-tax charges of $19,550,000 for the twelve months ended December 31, 2015 for an impairment of an investment in a joint venture with Gallup and a loss on the remaining investment commitment.  The tax rate applied to these losses was 39.55%, which represented the combined estimated U.S. federal and state statutory tax rate.

(5) EPS (loss) attributable to CEO transition-related expenses consists of pre-tax charges of $254,000 and $4,721,000 for the three and twelve months ended December 31, 2015, respectively, associated with the termination in May 2015 of our former President and Chief Executive Officer and transition to our new Chief Executive Officer.  The tax rate applied to these CEO transition-related expenses was 39.55%, which represented the combined estimated U.S. federal and state statutory tax rate.
 
- MORE -
HWAY Reports Fourth-Quarter Results
Page 10
February 25, 2016
 
(6) EPS (loss) attributable to a valuation allowance totals $9,615,000 for the three and twelve months ended December 31, 2015, respectively, and is the result of the recognition of a valuation allowance against U.S. deferred tax assets.

(7) EPS (loss) attributable to the gain on the sale of business consists of pre-tax charges of $1,873,000 for the three and twelve months ended December 31, 2015 associated with the gain on the sale of the Navvis business. The tax rate applied to this gain was 39.55%, which represented the combined estimated U.S. federal and state statutory tax rate.

(8) EPS (loss) attributable to legal settlement charges represents the impact of three legal settlements recorded in fiscal 2014.  Total pre-tax charges were $17,715,000, $9,363,000 of which was recorded in the first quarter of 2014 at a tax rate of 35.52%, which represented the estimated annualized effective tax rate for domestic operations at the time the charge was recorded. The two remaining legal settlements were recorded in the fourth quarter of 2014 at a tax rate of 35%, which represented the updated estimate of the annualized effective tax rate for domestic operations at the time the charges were recorded.

(9) Figures may not add due to rounding.
 
Reconciliation of Adjusted EBITDA
to Net Income (Loss) Including Non-Controlling Interest, GAAP Basis
(In thousands)

 
  
Twelve Months Ended
      
 
  
December 31, 2015
    
Margin %
  
Adjusted EBITDA (10)
  
$
70,589
      
9.2
%
Restructuring charges (11)
    
(15,097
)
        
Impairment charge and loss on related purchase commitment (12)
    
(19,550
)
        
Gain on sale of business (13)
    
1,873
          
CEO transition-related expenses (14)
    
(4,721
)
        
Depreciation and amortization
    
(49,855
)
        
Interest expense
    
(18,328
)
        
Income tax benefit
    
3,771
          
Net loss including non-controlling interest, GAAP basis
  
$
(31,318
)
        
                 

(10) Adjusted EBITDA is a non-GAAP financial measure.  The Company excludes restructuring charges, impairment charge and loss on related purchase commitment, gain on sale of business, and CEO-transition-related expenses from this measure because of its comparability to the Company's historical operating results.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider adjusted EBITDA in isolation or as a substitute for net loss including non-controlling interest determined in accordance with accounting principles generally accepted in the United States.

(11) Restructuring charges consists of pre-tax charges of $15,097,000 for the twelve months ended December 31, 2015 associated with a Company reorganization and rationalization plan.

(12) Impairment charge and loss on related purchase commitment consists of pre-tax charges of $19,550,000 for the twelve months ended December 31, 2015 for an impairment of an investment in a joint venture with Gallup and a loss on the remaining investment commitment.

(13) Gain on sale of business consists of a gain of $1,873,000 for the twelve months ended December 31, 2015 associated with the gain on the sale of the Navvis business.
 
- MORE -

HWAY Reports Fourth-Quarter Results
Page 11
February 25, 2016
 
(14) CEO transition-related expenses consists of pre-tax charges of $4,721,000 for the twelve months ended December 31, 2015 associated with the termination in May 2015 of our former President and Chief Executive Officer and transition to our new Chief Executive Officer.


Reconciliation of Adjusted EBITDA Excluding Non-Cash Share-Based Compensation
to Net Income (Loss) Including Non-Controlling Interest, GAAP Basis
(In thousands)

 
  
Twelve Months Ended
  
 
  
December 31, 2015
  
Adjusted EBITDA (15)
  
$
80,140
  
Non-cash share-based compensation (16)
    
(9,551
)
Restructuring charges (17)
    
(15,097
)
Impairment charge and loss on related purchase commitment (18)
    
(19,550
)
Gain on sale of business (19)
    
1,873
  
CEO transition-related expenses (20)
    
(4,721
)
Depreciation and amortization
    
(49,855
)
Interest expense
    
(18,328
)
Income tax benefit
    
3,771
  
Net loss including non-controlling interest, GAAP basis
  
$
(31,318
)
         

(15) Adjusted EBITDA is a non-GAAP financial measure.  The Company excludes restructuring charges, impairment charge and loss on related purchase commitment, gain on sale of business, and CEO-transition-related expenses from this measure because of its comparability to the Company's historical operating results.  Further, the Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management and are therefore excluding non-cash share-based compensation.  You should not consider adjusted EBITDA in isolation or as a substitute for net loss including non-controlling interest determined in accordance with accounting principles generally accepted in the United States.

(16) Non-cash share-based compensation charges consists of pre-tax charges of $9,551,000 for the twelve months ended December 31, 2015.

(17) Restructuring charges consists of pre-tax charges of $15,097,000 for the twelve months ended December 31, 2015 associated with a Company reorganization and rationalization plan.

(18) Impairment charge and loss on related purchase commitment consists of pre-tax charges of $19,550,000 for the twelve months ended December 31, 2015 for an impairment of an investment in a joint venture with Gallup and a loss on the remaining investment commitment.

(19) Gain on sale of business consists of a gain of $1,873,000 for the twelve months ended December 31, 2015 associated with the gain on the sale of the Navvis business.

(20) CEO transition-related expenses consists of pre-tax charges of $4,721,000 for the twelve months ended December 31, 2015 associated with the termination in May 2015 of our former President and Chief Executive Officer and transition to our new Chief Executive Officer.



- END -
 GRAPHIC 3 hwaylogo.jpg begin 644 hwaylogo.jpg M_]C_X 02D9)1@ ! 0$!+ $L #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MP +" *A!7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H " $! _ /U3HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHIK,L:LS,%51DL3@ >MNPL[ZVU"$36MQ%9"X=<_45/1111111111111111111111111111 M111111111111111111111111111111111111111111111111111111111111 M111111111111111111111111111111111111111111111111111111111111 M1111111111111111111111111117GGQ4_:$^&WP2M3-XY\:Z/X<;;O6VNKD& MYD7U2!/O^"S7QD\1/)'X:T3PWX1MCG8ZV[WEROU>1MA_[]BOGSQC^W=^T!XZWC4_B MOXBB63(9-+N!IRD'J,6PC&/:O'_$'C+7_%DQEUS7-2UF7=NWZA=R3MGDYRY/ M/S-^9]:RH87N)4BB1I)78*J(,EB> .YK>L?AWXKU16:S\,:S=JIPS0:?*X! M]#A:EN?ACXQLX'FN/">N00IRTDFFS*H^I*U@7EA:'=1WT>?[QC<1,H]@7/UKZ^^$O[:_ MP2^-?D1>%_B'I+ZA,0BZ9J,AL;MG/\*Q3!6<_P"YN'O7N%%%%%%%%%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%5M0U"UTFQGO;ZYALK.W0R37%Q( M(XXT R69B< =S7Q3^T!_P %9_A%\))+G3/"9F^)6O1%E*Z5((M/1A_>NB"& M'O$KCKR*_.CXW?\ !3SXZ?&0W%K;^(E\#:+)D"P\+AK9]O;=<$F8G'7#J#D_ M+CBOE.\O+C4+J6YNIY+FYE8O)-,Y=W8]22>2:]3^$/[*/Q;^/#1/X)\":MJ] MC(<#4GB%O9<'!_TB4K&2/0-GVK[.^%O_ 1/\::PL%SX_P#'6E>'(F 9K+1X M'OIP,?=9V\M%;W7>/K7U-X"_X)!_ 'PFL;:S:Z]XSF'+?VMJ;0QY]EMA$<>Q M)_&O>_"?['_P1\$H@TCX4^$X73[L]QI45Q,/^VDJL_ZUZCI.@Z9H$)ATO3K3 M38L >7:0+$N!G PH'3)_.K]%0W5I!?6[07,,=Q"V-T)K+ _P"!7$/] M(J^-_C!_P3[^._P56>YUCP+>:KI462=4\/D7\&T=781Y>-?>1%KYV93&Q5@5 M93@J1@@U[K\%?VW_ (T_ /[/!X8\;WTND0X T75C]MLMO7:LO MT.^ ?_!9SPCXF>VTWXK>'9O"-ZY"-K.D![JP/^T\7,L8]E\WZU^@?@7XA>&? MB=X=M]>\):]I_B+1Y_N7FG3K-'GNI(/RL,\J<$=Q70T44444444444444444 M444444444444444444444444444444444444444444444444444444444444 M444444444444444444444444444444444444444444444444444444444444 M444444444444444444444444445\4?M3_P#!4SX;? =KS0_"AC^(?C*+*-;V M$P%A:O\ ]-K@9#$?W(PQR""4K\E_VA/VPOBG^TUJ$C^,_$DSZ1YGF0:!89@T M^#G(Q$#\Y'9Y"S?[5>,1QO-(L<:L\C$*JJ,DD] !7V=^SK_P2K^+OQJ6TU3Q M% GPX\,RD,;C6HF-](A[QVHPW_?PQ@YR,U^E_P !_P#@FK\$/@:MO=_\(XOC M/7XL-_:OB8+=$-CJD&!$F#R#M+#^\<5]31QK#&L<:JD:@*JJ, = !3Z**** M******\5^.'[&_PA_:$AF?QAX-L9=5DZ:U8+]EOU/8F9,%\>C[E]J_-O]HG_ M ((W^,O!L=UJ_P *-97QMIB9<:-J)2WU)%]%?B*8]?\ GF>@"DU^?/B;POK/ M@O7+K1M?TJ]T35[1MD]CJ%N\$T3>C(P!'XBNB^%/QJ\<_ [Q$NN>!?$VH>&] M0XWM:2?NY@.BRQG*2+_LN"*_4']EW_@L5HOB)K30/C1IT?A[4&Q&GB;2XV>S MD/0&:$9:(^K+N7)Z(!7Z0Z#X@TSQ5H]IJ^BZC:ZMI5Y&);>]L9EFAF0]&1U) M##W!K0HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHKS[XV_'KP/^SSX M-E\3>.=PX Y) R:_&+]KS_@IEX__:.:^\/^ M'6F\#_#^3=$=.M9?]+OH^G^DS#L1_P LDPO.&+X!KXUKZ!_9<_8A^)7[5>IH M_AW3O[*\+1R;+KQ-J2E+2/'WEC[S.,?=3.#C<5!S7['?LO\ _!/OX5_LPPVU M_I^F_P#"3>,4&7\2:Q&KS(W&?(C^[ ,YP5^?!P7:OIFBBBBBBBBBBBBBBBO+ M?CQ^S+\.?VDO#_\ 97COP[;ZF\:%;74H_P!U>V>>9_'W@>+=(\UM#_ *?8QCG,\*_>4#K)'Q\I+*@KXEKW M/]F;]LKXD_LKZVLWA75FNM!DD#WGAW4"TEC<^I"YS&_^VF#P,Y'%?M7^R=^W M%\/?VL='5-&NO[$\7PQ![WPS?R#[1'Q\SQ-P)H\Y^9>0,;E7(%?15%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?+?[:'[>WA#]DO17T]!'XC^(-U#OL M= CDP(0<[9KEA]R/CA1\S]!@9=?PY^-7QT\:_M">-KGQ3XXUJ;5M2ERL49^6 M"TCSD10QCA$'H.3U))))X..-YI%CC5GD8A551DDGH *_3G]B7_@D[<>(8M/\ M;?&ZUFT_3FVSV?@_)CN)AU#79',:D?\ +(8?GYBN"I_5[0]"TWPSH]GI.CV% MKI6EV<8AMK*SA6*&%!P%1% "@>@%7Z****\6_:D_:P\$_LH^!CKGBBY^TZG< MAETO0K9A]IU"08R%_NHN1ND/"@]R54_)7_!/+]LGXX_M5?'[Q9)K\5D_PWMK M)I9+6WLXXXM+F9A]GCCF \R1F"OD.S<*Q&W %?H]1116!X^N-?M/ OB.?PI; M6]YXHBTVY?2;>Z.(9;P1,8$6=Q%=V M=Q<-Q X>.5& *LK#@@@@@CKFK%%%%%?!'[:G_!+;PS\;([WQ;\,XK/PAXY MP99K!5$>GZHW4[E Q#*?[ZC:Q^\,DN/QK\<>!?$'PU\4ZAX;\4:1=:'KEA(8 MKFQO$VNA]?0@CD,,@@@@D&J7A_Q!J?A36K+6-%U"YTK5;*436U[9RM%+#(.C M*P.0:_8#]A+_ (*D6'Q0;3O 7QP\0$"*UU)NBI+VBF)Z'A')P M-IP&_1BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBOAW_@H!_P44TW]F^Q MN_!'@F2'5?B9O];US4 M+C5M7OYFN+J]NY#)+-(QR69CR34>AZ'J/B;6;+2-(LKC4M4OIEM[6SM8S)+- M(QPJ*HY))(&!7[3?L"_\$U]*^ MM8^.?B-:V^L?$=AYEM9L5EM=&!Z;.SS^L MG(7HG0LWWI111117AW[6O[67A3]DOX)O&&NW,=C96D*[43(KK'82 M;&Z?,$/)_L^ZQ9^ /'5Y)>?#2^FVP7,I+/HY@) M.73^')=>=P?]M+&^MM3LK>\L[B*[L[B-9H;B!P\?VOOV+?!G[6_A$V^J1II'BZSB*Z5XD@B!FMSU$<@R/-B)ZH3QDE2I))_! MKXW?!#Q=^SW\0M1\'>,M-:PU2T;,C8X/4'((!! X*OT\_ MX)V_\%,)]#N-,^%_Q?U;S=(;;;:-XHO'RUJ1>68DDDGKFC2]+O=UMHS) M+-(Q 5$4AE(.'D'NJG;DO\ ;=%%%%%<%\./%=U]GTS38LK$A' MFW4QXC@B'=W; '8
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end